SEC Form 4 · accession 0001571049-15-001278
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas G Dagger
Officer — SVP, Gen Counsel and Corp Sec
Period of report
Feb 17, 2015
Accepted (ET)
Feb 19, 2015 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Feb 17, 2015 | M | 4,000 | $11.83 | A | 4,000 | D | |
| Class A Common StockF2 | Feb 17, 2015 | S | 4,000 | $31.91 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Class A Common Stock | $11.83 | Feb 17, 2015 | M | 4,000 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 4,000 | 18,100 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2014.
- F2Reflects the weighted average sale price of the Class A Common Stock sold. The shares were sold in multiple trades at prices ranging from $31.00 to $32.77 per share. The Reporting Person will provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.